Welcome! This is the NEW free version of the SciBITES Pharma News Engine from SciBite. By using this site you to accept our Terms & Conditions which the use of cookies to enhance your user experience.


Here is the latest news for your query in chronological order, most recent articles at the top. Use the options on the right to filter and customise this news feed.

  Todays Drug Approval Feed Articles ...

Systematic integration of biomedical knowledge prioritizes drugs for repurposing.
Medline, eLife [6], 24-Sep-2017
The European Medicines Agency Review of Carfilzomib for the Treatment of Adult Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy.
Medline, The oncologist, 24-Sep-2017
3D image guidance assisted identification of colorectal cancer liver metastases not seen on intraoperative ultrasound: results from a prospective trial.
Medline, HPB : the official journal of the International Hepato Pancreato Biliary Association, 24-Sep-2017
Bortezomib Alone and in Combination with Salinosporamid A Induces Apoptosis and Promotes Pheochromocytoma Cell Death in Vitro and in Female Nude Mice.
Medline, Endocrinology, 24-Sep-2017
Effects of ticagrelor in a mouse model of ischemic stroke.
Medline, Scientific reports [7] 12088, 24-Sep-2017
Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury.
Medline, Scientific reports [7] 12064, 24-Sep-2017
Process signatures in glatiramer acetate synthesis: structural and functional relationships.
Medline, Scientific reports [7] 12125, 24-Sep-2017
Neurological toxicities associated with immune-checkpoint inhibitors.
Medline, Current opinion in neurology, 24-Sep-2017
Impact of Different Integrase Inhibitor Based Regimen on Markers of Inflammation and Immune Activation Among HIV naïve Patient During the First Year of Effective First-line Combination
ClinicalTrials.gov, , 24-Sep-2017
An Ancillary Study Protocol to GlaxoSmithKline Phase IIb RTS,S/AS01E Malaria Vaccine Trial (Study Number 204889 [MALARIA-094]) Entitled, "Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age"
ClinicalTrials.gov, , 24-Sep-2017
A Phase II Trial of Ibrutinib in Newly Diagnosed Mantle Cell Lymphoma With Low-Risk Disease
ClinicalTrials.gov, , 24-Sep-2017
A Phase 0 Open Label, Single-center Clinical Trial of ABY-029, an Anti-EGFR Fluorescence Imaging Agent Via Single Intravenous Injection to Subjects With Operable Head and Neck Cancer.
ClinicalTrials.gov, , 24-Sep-2017
Testing an Integrated Bio-Behavioral Primary HIV Prevention Intervention Among High-Risk People Who Use Drugs
ClinicalTrials.gov, , 24-Sep-2017
Phase 1 Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov, , 24-Sep-2017
A Safety Study of Daratumumab, Ixazomib, and Dexamethasone in Previously Treated Amyloid Light Chain (AL) Amyloidosis
ClinicalTrials.gov, , 24-Sep-2017
Excess Opioid Disposal Following Orthopedic Foot and Ankle Surgery
ClinicalTrials.gov, , 24-Sep-2017
A Phase III/IV, Single Arm, Multicenter Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (TAIL)
ClinicalTrials.gov, , 24-Sep-2017
Local Control, Quality of Life and Toxicities in Adults With Benign or Indolent Brain Tumors Undergoing Proton Radiation Therapy
ClinicalTrials.gov, , 24-Sep-2017
A Prospective Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma
ClinicalTrials.gov, , 24-Sep-2017
First-in-human Phase Ia/II Clinical Trial of a Combined Immune Modulatory Approach Using TetMYB Vaccine and Anti-PD1 Antibody in Patients With Advanced Solid Cancer Including Colorectal or Adenoid Cystic Carcinoma.
ClinicalTrials.gov, , 24-Sep-2017
Showing Records 0 ... 20  


SciBite
The Language Of Science

SciBite provides text-analytics and data intelligence software for drug discovery, clinical and competitor intelligence and much more for pharma, healthcare and life sciences.

This is a Limited, Free Service only touching the surface of how SciBite's tools transform biomedical text, literature, patents, internal documents and news into a rich intelligence network. If you'd like to know more, contact us to see how our tools can transform your work today!

Topic Activity & Tools

Get Daily Alerts!

Click For Email & RSS Alerts

About/Links

Query: Drug Approval Feed
Type: Query